190 related articles for article (PubMed ID: 9808176)
1. Differential reactivity of TCR Vbeta10 alleles to a mouse mammary tumor virus superantigen.
Maillard I; Xenarios I; Diggelmann H; Orbea HA
Eur J Immunol; 1998 Oct; 28(10):3075-85. PubMed ID: 9808176
[TBL] [Abstract][Full Text] [Related]
2. Mutational and functional analysis of the C-terminal region of the C3H mouse mammary tumor virus superantigen.
Wrona TJ; Lozano M; Binhazim AA; Dudley JP
J Virol; 1998 Jun; 72(6):4746-55. PubMed ID: 9573239
[TBL] [Abstract][Full Text] [Related]
3. T cell receptor V beta repertoire in mice lacking endogenous mouse mammary tumor provirus.
Braun MY; Jouvin-Marche E; Marche PN; MacDonald HR; Acha-Orbea H
Eur J Immunol; 1995 Mar; 25(3):857-62. PubMed ID: 7705418
[TBL] [Abstract][Full Text] [Related]
4. Identification of key amino acids of the mouse mammary tumor virus superantigen involved in the specific interaction with T-cell receptor V(beta) domains.
Baribaud F; Wirth S; Maillard I; Valsesia S; Acha-Orbea H; Diggelmann H
J Virol; 2001 Aug; 75(16):7453-61. PubMed ID: 11462017
[TBL] [Abstract][Full Text] [Related]
5. In vivo effects of a recombinant vaccinia virus expressing a mouse mammary tumor virus superantigen.
Krummenacher C; Diggelmann H; Acha-Orbea H
J Virol; 1996 May; 70(5):3026-31. PubMed ID: 8627779
[TBL] [Abstract][Full Text] [Related]
6. A V beta 4-specific superantigen encoded by a new exogenous mouse mammary tumor virus.
Maillard I; Erny K; Acha-Orbea H; Diggelmann H
Eur J Immunol; 1996 May; 26(5):1000-6. PubMed ID: 8647159
[TBL] [Abstract][Full Text] [Related]
7. Alleviation of renal disease and lymphadenopathy in MRL-Fasp(lrcg)/Fas(lprcg) (MR-lpr(cg)) mice neonatally infected with mouse mammary tumor virus encoding superantigen strongly reactive with TCR Vbeta8.2 element.
Matsuzawa A; Yasuda T; Zhang Y; Nagase H; Yoshimoto T; Kimura M; Tsubura A
Viral Immunol; 2000; 13(3):297-311. PubMed ID: 11016595
[TBL] [Abstract][Full Text] [Related]
8. A V beta 8.2-specific superantigen from exogenous mouse mammary tumor virus carried by FM mice.
Yoshimoto T; Nagase H; Nakano H; Matsuzawa A; Nariuchi H
Eur J Immunol; 1994 Jul; 24(7):1612-9. PubMed ID: 7913038
[TBL] [Abstract][Full Text] [Related]
9. CD28/CTLA4-B7 interaction is dispensable for T cell stimulation by mouse mammary tumor virus superantigen but not for B cell differentiation and virus dissemination.
Champagne E; Scarpellino L; Lane P; Acha-Orbea H
Eur J Immunol; 1996 Jul; 26(7):1595-602. PubMed ID: 8766566
[TBL] [Abstract][Full Text] [Related]
10. Role of dendritic cells in the immune response induced by mouse mammary tumor virus superantigen.
Baribaud F; Maillard I; Vacheron S; Brocker T; Diggelmann H; Acha-Orbea H
J Virol; 1999 Oct; 73(10):8403-10. PubMed ID: 10482591
[TBL] [Abstract][Full Text] [Related]
11. Characterization of mouse mammary tumour virus-induced migration of lymphoid cells into lymph nodes.
Matsuzawa A; Yasuda T; Sakamoto S; Nagase H; Nakano H; Yoshimoto T
Scand J Immunol; 2001 Jun; 53(6):553-62. PubMed ID: 11422903
[TBL] [Abstract][Full Text] [Related]
12. Chronic deletion, escape from deletion and activation of mouse mammary tumor virus superantigen-reactive T cells in C57BL/10 mice.
Dyson PJ; Elliott JI
Eur J Immunol; 1999 May; 29(5):1456-66. PubMed ID: 10359099
[TBL] [Abstract][Full Text] [Related]
13. In vitro negative selection of viral superantigen-reactive thymocytes by thymic dendritic cells.
Ferrero I; Anjuère F; MacDonald HR; Ardavín C
Blood; 1997 Sep; 90(5):1943-51. PubMed ID: 9292528
[TBL] [Abstract][Full Text] [Related]
14. New infectious mammary tumor virus superantigen with V beta-specificity identical to staphylococcal enterotoxin B (SEB).
Luther S; Shakhov AN; Xenarios I; Haga S; Imai S; Acha-Orbea H
Eur J Immunol; 1994 Aug; 24(8):1757-64. PubMed ID: 8056034
[TBL] [Abstract][Full Text] [Related]
15. Pairing of Vbeta6 with certain Valpha2 family members prevents T cell deletion by Mtv-7 superantigen.
Aude-Garcia C; Attinger A; Housset D; MacDonald HR; Acha-Orbea H; Marche PN; Jouvin-Marche E
Mol Immunol; 2000 Nov; 37(16):1005-12. PubMed ID: 11395139
[TBL] [Abstract][Full Text] [Related]
16. Association of a V beta 2-specific superantigen with a tumorigenic milk-borne mouse mammary tumor virus.
Hodes RJ; Novick MB; Palmer LD; Knepper JE
J Immunol; 1993 Feb; 150(4):1422-8. PubMed ID: 8094408
[TBL] [Abstract][Full Text] [Related]
17. Characterization of two infectious mouse mammary tumour viruses: superantigenicity and tumorigenicity.
Buggiano V; Goldman A; Nepomnaschy I; Bekinschtein P; Berguer P; Lombardi G; Deroche A; Francisco MV; Piazzon I
Scand J Immunol; 1999 Mar; 49(3):269-77. PubMed ID: 10102644
[TBL] [Abstract][Full Text] [Related]
18. In vivo T cell response to viral superantigen. Selective migration rather than proliferation.
Le Bon A; Lucas B; Vasseur F; Penit C; Papiernik M
J Immunol; 1996 Jun; 156(12):4602-8. PubMed ID: 8648102
[TBL] [Abstract][Full Text] [Related]
19. Maternal transfer of infectious mouse mammary tumor retroviruses does not depend on clonal deletion of superantigen-reactive V beta 14+ T cells.
Penninger JM; Wallace VA; Timms E; Mak TW
Eur J Immunol; 1994 May; 24(5):1102-8. PubMed ID: 8181521
[TBL] [Abstract][Full Text] [Related]
20. [Viral superantigens].
Us D
Mikrobiyol Bul; 2016 Jul; 50(3):491-504. PubMed ID: 27525406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]